ScienceDex / Researcher record
Lon S Schneider
- University of Southern California · Neurology (NIH department code)
From the FY2026 NIH awards this investigator leads as contact PI. The department is the award's.
FY2026 NIH rank #617
- Program Leader
- Top 5% Funded
- R01 Holder
- Early Career
NIH Funding · FY2026
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
Linked awards ($M)Award-linked rank
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2024 | $2,243,861 | 1 | #4,376 |
| 2025 | $14,538,103 | 4 | #214 |
| 2026 | $11,769,746 | 3 | #617 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY20241 record
- FY20254 records
- FY2026 · selected3 records
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 1960378Search this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2027.
FY2026 award categories
- Neurology
FY2026 award records by amount
NIH award records listing Lon S Schneider as a PI. Multi-PI records show the full award amount for context.
- 5R01AG092949-02R01Co-investigatorFDA approved IND 29644: Multicenter Phase 1 Trial to Evaluate Safety and Immunogenicity of Preventive Tau Vaccine, AV-1980R/A, in cognitively unimpaired preclinical AD participants.$4.9Maward amount
- 5P30AG066530-07P30Contact PIAlzheimer's Disease Research CentersUniversity of Southern California · Neurology (NIH department code)$4.7Maward amount
- 5R01AG074983-05R01Co-investigatorSafety/Tolerability/Immunogenicity of first-in-human Aβ DNA vaccine, AV-1959D Phase 1 trials in early-stage AD subjects: based on IND18953 cleared by FDA.$2.1Maward amount
Award organizations
Organizations that administered FY2026 awards listing Lon S Schneider as a PI.
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardInstitute for Molecular Medicine
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024$2M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #4376
- 2024Entered Top 25% NationallyRanked #4376
- 2025$5M Cumulative Funding
- 2025$10M Cumulative Funding
- 2025Entered Top 10% NationallyRanked #214
- 2025Entered Top 5% NationallyRanked #214
- 2025Multi-Institutional ResearchAwards at 2 institutions
- 2025R01 Grant Holder
- 2025Program/Center Grant Leader
- 2026$25M Cumulative Funding
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as Lon S Schneider.
Michael G Agadjanyan
Institute for Molecular Medicine
5
shared awards
David Sultzer
Institute for Molecular Medicine
3
shared awards
Annie E Hiniker
University of Southern California
2
shared awards
Arthur W Toga
University of Southern California
2
shared awards
Duygu Tosun-Turgut
Institute for Molecular Medicine
2
shared awards
Helena Chang Chui
University of Southern California
2
shared awards
Hussein N Yassine
University of Southern California
2
shared awards
James E Galvin
Institute for Molecular Medicine
2
shared awards
Maria P. Aranda
University of Southern California
2
shared awards
Robert Rissman
University of Southern California
2
shared awards